The high stakes involved in cancer research, from potential life-saving treatments to substantial financial returns, make IP disputes prevalent. Companies, universities, and research institutions often vie for control over patents related to groundbreaking technologies and methodologies. Disputes can arise over the ownership, licensing, and infringement of these IP rights.
